Cargando…
Repurposing chlorpromazine in the treatment of glioblastoma multiforme: analysis of literature and forthcoming steps
BACKGROUND: Glioblastoma multiforme is a CNS cancer characterized by diffuse infiltrative growth, aggressive clinical behavior and very poor prognosis. The state-of-art clinical approach to this disease consists of surgical resection followed by radiotherapy plus concurrent and adjuvant chemotherapy...
Autores principales: | Abbruzzese, Claudia, Matteoni, Silvia, Persico, Michele, Villani, Veronica, Paggi, Marco G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995164/ https://www.ncbi.nlm.nih.gov/pubmed/32005270 http://dx.doi.org/10.1186/s13046-020-1534-z |
Ejemplares similares
-
Molecular Biology in Glioblastoma Multiforme Treatment
por: Abbruzzese, Claudia, et al.
Publicado: (2022) -
Drug repurposing for the treatment of glioblastoma multiforme
por: Abbruzzese, Claudia, et al.
Publicado: (2017) -
Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma
por: Persico, Michele, et al.
Publicado: (2022) -
Chlorpromazine induces cytotoxic autophagy in glioblastoma cells via endoplasmic reticulum stress and unfolded protein response
por: Matteoni, Silvia, et al.
Publicado: (2021) -
Anticancer Properties of the Antipsychotic Drug Chlorpromazine and Its Synergism With Temozolomide in Restraining Human Glioblastoma Proliferation In Vitro
por: Matteoni, Silvia, et al.
Publicado: (2021)